中国药业
中國藥業
중국약업
China Pharmaceuticals
2015年
19期
60-61,62
,共3页
抗肿瘤药物%成都地区医院%药物利用
抗腫瘤藥物%成都地區醫院%藥物利用
항종류약물%성도지구의원%약물이용
anti-tumor agents%hospitals of Chengdu Area%medication tendency
目的:分析2011年至2013年成都地区11家医院抗肿瘤药物临床应用情况,为临床合理用药提供依据,为生产、营销和使用提供参考。方法统计“医院处方分析”课题中成都地区11家样本医院提供的2011年至2013年抗肿瘤药物中各大类及品种金额、份额、增长率、复合年增长率、用药频度( DDDs )等,结合临床应用进行分析。结果3年来抗肿瘤药物需求量迅速增长,销售金额、DDDs呈上升趋势,抗代谢类药物一直居销售排行榜首,其中替吉奥近两年来药物单品种销售金额及DDDs均居首位。结论成都地区医院抗肿瘤药物用量呈上升趋势,开发高效、低毒、价廉的抗肿瘤药物是当今迫切的任务。
目的:分析2011年至2013年成都地區11傢醫院抗腫瘤藥物臨床應用情況,為臨床閤理用藥提供依據,為生產、營銷和使用提供參攷。方法統計“醫院處方分析”課題中成都地區11傢樣本醫院提供的2011年至2013年抗腫瘤藥物中各大類及品種金額、份額、增長率、複閤年增長率、用藥頻度( DDDs )等,結閤臨床應用進行分析。結果3年來抗腫瘤藥物需求量迅速增長,銷售金額、DDDs呈上升趨勢,抗代謝類藥物一直居銷售排行榜首,其中替吉奧近兩年來藥物單品種銷售金額及DDDs均居首位。結論成都地區醫院抗腫瘤藥物用量呈上升趨勢,開髮高效、低毒、價廉的抗腫瘤藥物是噹今迫切的任務。
목적:분석2011년지2013년성도지구11가의원항종류약물림상응용정황,위림상합리용약제공의거,위생산、영소화사용제공삼고。방법통계“의원처방분석”과제중성도지구11가양본의원제공적2011년지2013년항종류약물중각대류급품충금액、빈액、증장솔、복합년증장솔、용약빈도( DDDs )등,결합림상응용진행분석。결과3년래항종류약물수구량신속증장,소수금액、DDDs정상승추세,항대사류약물일직거소수배행방수,기중체길오근량년래약물단품충소수금액급DDDs균거수위。결론성도지구의원항종류약물용량정상승추세,개발고효、저독、개렴적항종류약물시당금박절적임무。
Objective To investigate the utilization trend of anti-tumor agents in the 11 hospitals in Chengdu for reference of clinical rational drug use during 2011-2013. Methods Data for anti-tumor agents in 11 hospitals of Chengdu during 2011-2013 were used to count the sales, shares, growth rates, DDDs and compound annual growth rate of statistical categories and varieties, which were ana-lyzed by combination with their application in clinic. Results The anti-tumor agents used in Chengdu hospitals continue to grow up during the 3 years. The anti-metabolism agents sales has been the first during 3 years, and the sales amount and DDDs of the maxi-mum is TS-1. Conclusion The use of anti-tumor drugs assumes an increasingly important role in clinical treatment. Development of high efficiency, low toxicity, low price of the anti-tumor agents is the urgent task.